Qilian International Holding Group Limited
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian S… Read more
Qilian International Holding Group Limited (BGM) - Net Assets
Latest net assets as of March 2025: $183.49 Million USD
Based on the latest financial reports, Qilian International Holding Group Limited (BGM) has net assets worth $183.49 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($207.39 Million) and total liabilities ($23.90 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $183.49 Million |
| % of Total Assets | 88.47% |
| Annual Growth Rate | 18.22% |
| 5-Year Change | 52.88% |
| 10-Year Change | N/A |
| Growth Volatility | 34.86 |
Qilian International Holding Group Limited - Net Assets Trend (2017–2024)
This chart illustrates how Qilian International Holding Group Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Qilian International Holding Group Limited (2017–2024)
The table below shows the annual net assets of Qilian International Holding Group Limited from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | $44.09 Million | -0.58% |
| 2023-09-30 | $44.35 Million | -19.31% |
| 2022-09-30 | $54.96 Million | -3.01% |
| 2021-09-30 | $56.67 Million | +96.48% |
| 2020-09-30 | $28.84 Million | +27.40% |
| 2019-09-30 | $22.64 Million | +27.74% |
| 2018-09-30 | $17.72 Million | +29.76% |
| 2017-09-30 | $13.66 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Qilian International Holding Group Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 42.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $4.35 Million | 10.18% |
| Common Stock | $59.58K | 0.14% |
| Other Comprehensive Income | $1.92 Million | 4.50% |
| Other Components | $36.41 Million | 85.18% |
| Total Equity | $42.74 Million | 100.00% |
Qilian International Holding Group Limited Competitors by Market Cap
The table below lists competitors of Qilian International Holding Group Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Linkage Global Inc Ordinary Shares
NASDAQ:LGCB
|
$2.55 Million |
|
Botala Energy Ltd
AU:BTE
|
$2.55 Million |
|
Pathfinder Ventures Inc
OTCQB:RVRVF
|
$2.55 Million |
|
PT Chemstar Indonesia Tbk
JK:CHEM
|
$2.55 Million |
|
GREENHY2 Ltd
AU:H2G
|
$2.55 Million |
|
Reward Minerals Ltd
AU:RWD
|
$2.55 Million |
|
Hensel Davest Indonesia Tbk PT
JK:HDIT
|
$2.55 Million |
|
Treasure Global Inc.
NASDAQ:TGL
|
$2.55 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Qilian International Holding Group Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 42,792,133 to 42,743,844, a change of -48,289 (-0.1%).
- Net loss of 1,442,830 reduced equity.
- Other comprehensive income increased equity by 1,498,707.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.44 Million | -3.38% |
| Other Comprehensive Income | $1.50 Million | +3.51% |
| Other Changes | $-104.17K | -0.24% |
| Total Change | $- | -0.11% |
Book Value vs Market Value Analysis
This analysis compares Qilian International Holding Group Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.15x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.56x to 0.15x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-09-30 | $1.61 | $0.90 | x |
| 2018-09-30 | $2.19 | $0.90 | x |
| 2019-09-30 | $2.84 | $0.90 | x |
| 2020-09-30 | $3.73 | $0.90 | x |
| 2021-09-30 | $8.05 | $0.90 | x |
| 2022-09-30 | $7.34 | $0.90 | x |
| 2023-09-30 | $5.92 | $0.90 | x |
| 2024-09-30 | $5.91 | $0.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Qilian International Holding Group Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.75%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 1.24x
- Recent ROE (-3.38%) is below the historical average (9.84%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 12.58% | 6.28% | 0.68x | 2.97x | $290.45K |
| 2018 | 33.74% | 10.26% | 1.51x | 2.18x | $3.64 Million |
| 2019 | 26.80% | 11.57% | 1.31x | 1.77x | $3.34 Million |
| 2020 | 19.40% | 10.12% | 1.04x | 1.84x | $2.45 Million |
| 2021 | 5.75% | 5.52% | 0.76x | 1.37x | $-2.33 Million |
| 2022 | 2.03% | 1.66% | 1.01x | 1.22x | $-4.23 Million |
| 2023 | -18.18% | -16.74% | 0.91x | 1.20x | $-12.06 Million |
| 2024 | -3.38% | -5.75% | 0.47x | 1.24x | $-5.72 Million |
Industry Comparison
This section compares Qilian International Holding Group Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Qilian International Holding Group Limited (BGM) | $183.49 Million | 12.58% | 0.13x | $2.55 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |